Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency

被引:41
作者
Aalto, H
Takala, A
Kautiainen, H
Repo, H
机构
[1] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Anaesthesiol & Intens Care Med, Dept Surg, Helsinki 00029, Finland
[3] Rheumatism Fdn Hosp, Heinola 18120, Finland
[4] Univ Helsinki, Cent Hosp, Dept Med, Helsinki 00029, Finland
关键词
D O I
10.1007/s10096-004-1191-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the present study was to determine whether the presence of an infectious focus or of fever alone can predict bloodstream infection and whether levels of C-reactive protein, procalcitonin, interleukin (IL)-6, IL-8, and soluble IL-2 receptor (sIL-2R) improve the diagnosis of community-acquired bloodstream infection. Markers of systemic inflammation were studied in 92 patients with community-acquired infection. On admission to hospital, 54 patients had an infectious focus, 25 had fever without an infectious focus, and 13 had neither. The presence of focus or fever predicted bloodstream infection (n=13 patients) with a sensitivity of 100% (95% confidence interval, 75-100), a specificity of 16% (95% CI, 9-26), a negative predictive value of 100% (95% CI, 75-100), and a positive predictive value of 16% (95% CI, 9-26). Positive predictive values of C-reactive protein, procalcitonin, IL-6, IL-8, and sIL-2R, all measured on admission, were also low (33-44%). Eight febrile patients in whom an infectious focus was found during a 3-day follow-up period had higher on-admission IL-6 (P=0.005) and sIL-2R (P=0.046) levels than did 17 febrile patients without an infectious focus. In conclusion, markers of systemic inflammation do not improve the diagnosis of community-acquired bloodstream infection; however, they may aid in identifying patients with fever due to occult infection.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 21 条
[1]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[3]   Prediction of shock in febrile medical patients with a clinical infection [J].
Bossink, AWJ ;
Groeneveld, ABJ ;
Koffeman, GI ;
Becker, A .
CRITICAL CARE MEDICINE, 2001, 29 (01) :25-31
[4]   CLINICAL IMPLICATIONS OF POSITIVE BLOOD CULTURES [J].
BRYAN, CS .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (04) :329-353
[5]   RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6/BSF-2/HSF) REGULATES THE SYNTHESIS OF ACUTE PHASE PROTEINS IN HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
HIRANO, T ;
KISHIMOTO, T ;
HEINRICH, PC .
FEBS LETTERS, 1988, 232 (02) :347-350
[6]   Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever [J].
Chirouze, C ;
Schuhmacher, H ;
Rabaud, C ;
Gil, H ;
Khayat, N ;
Estavoyer, JM ;
May, T ;
Hoen, B .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) :156-161
[7]   AFEBRILE BACTEREMIA - A PHENOMENON IN GERIATRIC-PATIENTS [J].
GLECKMAN, R ;
HIBERT, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (12) :1478-1481
[8]  
ISPAHANI P, 1987, Q J MED, V63, P427
[9]  
Jones GR, 1996, QJM-MON J ASSOC PHYS, V89, P515
[10]   Pathobiochemistry and clinical use of procalcitonin [J].
Meisner, M .
CLINICA CHIMICA ACTA, 2002, 323 (1-2) :17-29